POETA: Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia

Sponsor
Medical University of Vienna (Other)
Overall Status
Recruiting
CT.gov ID
NCT02518542
Collaborator
(none)
400
1
4
156
2.6

Study Details

Study Description

Brief Summary

Achalasia is an esophageal motility disorder, which leads to clinical symptoms such as dysphagia, regurgitation, chest pain and consecutive weight loss.

Although conventional treatment such as laparoscopic Heller myotomy (LHM) and balloon dilatation (BD) can provide sufficient symptom relief in many patients, both interventions have their individual drawbacks. Additionally, treatment after failed LHM or BD can be challenging and in few might even lead to esophagectomy.

Per oral endoscopic myotomy (POEM) and prolonged dilatation (PRD) are two novel endoscopically performed therapeutic options for achalasia and other esophageal motility disorders. Both not only appear to provide good results, when performed as initial treatment but also might be an excellent option after e.g failed LHM.

The purpose of this study is to evaluate the long-term efficacy of four different treatment options, such as POEM, PRD with stent-fixation, PD and conventional LHM for achalasia in an individualized treatment setting.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic intervention A
  • Procedure: Endoscopic intervention B
  • Procedure: Endoscopic intervention C
  • Procedure: Laparoscopic Surgery
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) as Additional Endoscopic Treatment Options for Achalasia and Other Esophageal Motility Disorders
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Per oral endoscopic therapy A

Per oral endoscopic myotomy

Procedure: Endoscopic intervention A
POEM: Per oral endoscopic myotomy

Active Comparator: Per oral endoscopic therapy B

Prolonged dilatation by implantation of large diameter stents.

Procedure: Endoscopic intervention B
PRD: Prolonged dilatation by temporary implantation of large diameter stent . Stents are additionally attached to the esophageal wall by different technical options.

Active Comparator: Per oral endoscopic therapy C

Dilatation

Procedure: Endoscopic intervention C
Endoscopic balloon dilatation

Active Comparator: Laparoscopic surgery

Laparoscopic Heller myotomy

Procedure: Laparoscopic Surgery
Laparoscopic Heller myotomy

Outcome Measures

Primary Outcome Measures

  1. Achalasia specific symptoms according to the Eckardt score (0-12) [6 mo post-op]

    Eckardt score: Weight loss 0kg (0), less than 5kg (1), 5-10 kg (2), more than 10 kg (3); Dysphagia none(0), occasional (1), daily (2), every meal (3); Regurgitation none(0), occasional (1), daily (2), every meal (3); Retrosternal pain none(0), occasional (1), daily (2), every meal (3)

Secondary Outcome Measures

  1. Barium column height (cm) in esophagogram [6 mo post-op]

  2. Resting pressure (mmHg) at the lower esophageal sphincter [6 mo post-op]

  3. Stent migration [p.o. day 1]

    Analysis: On the first postoperative day a routine esophagogram will be used to evaluate the appropriate location of the esophageal stent. Early distal stent dislocation/migration into the stomach will be registered.

  4. Percent of time (min)/24h that the pH is less than 4.0 in pH-metry [6 mo post-op]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed diagnosis of achalsia, hypertensive lower esophageal sphincter, nutcracker esophagus, or diffuse esophageal spasm
Exclusion Criteria:
  • Contraindication for EGD

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Surgery, Medical University of Vienna Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Erwin Rieder, Priv. Doz. Dr. Erwin Rieder, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT02518542
Other Study ID Numbers:
  • POETA
First Posted:
Aug 10, 2015
Last Update Posted:
Aug 10, 2015
Last Verified:
Aug 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2015